About
Marginum is a university-based medical technology startup developing fluorescence-based tissue detection systems. The Company's data-driven solutions enable safe and efficient monitoring of tumor tissues during cancer surgery without compromising pre-existent surgical workflows. The products are derived from state-of-the-art research to improve surgical performance and cost-effectiveness. Marginum's multidisciplinary team works in close cooperation with academic, clinical and industrial experts to ensure its technological solutions' seamless clinical compatibility.
Technologies
Outlook
Microsoft Office 365
Microsoft Azure Hosting
Mobile Friendly
Bootstrap Framework
Vimeo
Google Tag Manager
reCAPTCHA
Apache
Keywords
medical equipment manufacturing
data-driven solutions
multidisciplinary research
medical devices
diagnostic imaging
minimally invasive detection
clinical trials in neurosurgery
medical device
government
surgical tissue monitoring
b2b
u.s. fda clearance
tissue recognition technology
cancer tissue detection
healthcare technology
fluorescence-guided surgery
services
surgical workflow integration
cancer surgery technology
medical technology
oncological surgery
medical equipment and supplies manufacturing
clinical compatibility
fluorescent biomarkers
medical device development
aspirate tissue monitoring
surgical equipment
real-time tissue monitoring
fluorescence-based tissue detection
healthcare
Company Information
-
Employees 8
-
Founded 2020
Location
Kuopio, Finland
